Kam Lawrence

Concentrated strategySector-focusedLong-term holder

Total reported value

$97.4M

Reporting period: 2019-12-31 · Number of holdings: 7

Kam Lawrence disclosed 7 holdings in its latest 13F filing for the period ending 2019-12-31, with total reported value of $97.4M and a quarterly turnover rate of 0.0%.

Browse other institutions with under $100M AUM Browse other institutions starting with "K"

Personality snowflake

Concentration: 100
Portfolio Stability: 0
Momentum/Contrarian: 50
Sector conviction: 100
Diversification: 14
Sizing Uniformity: 88.59

Recent moves

No holding changes this quarter

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	ADVMCHF	Adverum Biotechnologies INC	Stock-Other	47.83%	—	—	—
2	RGNX	Regenxbio INC	Stock-Other	19.59%	—	—	—
3	SRPT	Sarepta Therapeutics INC	Stock-Healthcare	14.93%	—	—	—
4	GNW	Genworth Financial INC	Stock-Financials	9.48%	—	—	—
5	FENC	Fennec Pharmaceuticals INC	Stock-Other	5.56%	—	—	—
6	✓	Third Pt Reins LTD	Stock-Other	2.45%	—	—	—
7	TROX	Tronox Holdings plc	Stock-Other	0.15%	—	—	—

Reported value over time

Not enough data yet to compute personality scores

Sector allocation

Sector allocation over time

Not enough sector-mapped data yet

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2019-12-31	7	$97.4M	0	1ADVMCHF 2RGNX 3SRPT Top holdings2019-12-31 1.ADVMCHF 2.RGNX 3.SRPT 4.GNW 5.FENC 6.G8827U 7.TROX

Holding changes this quarter

Position changes disclosed by Kam Lawrence for the quarter ending 2019-12-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action

FAQ

What is Kam Lawrence and what type of investor is it?

Kam Lawrence is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2019-12-31), the firm manages a tracked equity portfolio valued at approximately $97.4M, spread across 7 disclosed positions.

What are Kam Lawrence's largest equity positions?

Based on the latest 13F filing, Kam Lawrence's top holdings by market value are: 1. Adverum Biotechnologies INC (ADVMCHF) — $46.6M (47.8%) 2. Regenxbio INC (RGNX) — $19.1M (19.6%) 3. Sarepta Therapeutics INC (SRPT) — $14.5M (14.9%) 4. Genworth Financial INC (GNW) — $9.2M (9.5%) 5. Fennec Pharmaceuticals INC (FENC) — $5.4M (5.6%)

What changes did Kam Lawrence make in its most recent portfolio filing?

No notable portfolio changes were recorded for Kam Lawrence in the most recent quarter. Holdings appear to have remained relatively stable.

What sectors does Kam Lawrence focus on?

Kam Lawrence is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 61.2% • Financials: 38.8%